Mr Daniel Morganstein, Consultant Endocrinologist

Mr Daniel Morganstein

Consultant Endocrinologist

Book online
|

Mr Daniel Morganstein MA (Cantab) FRCP PhD

Consultant Endocrinologist

MA (Cantab) FRCP PhD

Mr Daniel Morganstein

Consultant Endocrinologist MA (Cantab) FRCP PhD

Book online
|
MA (Cantab) FRCP PhD
HCA-Healthcare-UK

Areas of expertise

  • Endocrine tumours (thyroid, adrenal, neuroendocrine tumours, paragangliomas)
  • Endocrine effects of cancer treatment
  • Diabetes, especially diabetes management during cancer treatment
  • Pituitary disorders
  • Hyperthyroidism
HCA-Healthcare-UK

Address

About Mr Daniel Morganstein

GMC number: 4518925

Year qualified: 1998

Place of primary qualification: University of London

Mr Daniel Morganstein is a Consultant Endocrinologist based at Chelsea & Westminster Hospital NHS Trust. He is also an Honorary Clinical Senior Lecturer at Imperial College and sees patients privately, including at The Lister Hospital. Mr Morganstein studied at Cambridge University and qualified from St Bartholomew's and the Royal London in 1998He trained in endocrinology on the Hammersmith Rotation and undertook research at Imperial College, where he attained a PhD.
He specialises in all aspects of diabetes and endocrinology, with particular interests in endocrine tumours, including neuroendocrine tumours, adrenal tumours, and paragangliomas, as well as thyroid cancer, including medullary thyroid cancer, and pituitary disease
Mr Morganstein has a further interest in the management of diabetes during cancer treatment and the hormonal effects of cancer treatments. He also provides Diabetes and Endocrinology Services to the Royal Marsden Hospital and the local Community Diabetes ServiceHe has published papers in endocrine oncologyDiseases, Medical Tests and Treatments

Areas of expertise

  • Acromegaly or gigantism
  • Addison's disease
  • Adrenal disease
  • Cushing's syndrome
  • Diabetes and cancer including steroid induced cancer
  • Diabetes insipidus
  • Diabetes
  • Endocrine hypertension
  • Endocrine side effects of cancer treatment (including immunotherapy)
  • Endocrine tumours
  • General endocrinology
  • Goitre
  • Graves' disease
  • Hashimoto's thyroiditis
  • Hormone disorders (male)
  • Hyperthyroidism
  • Medullary thyroid cancer
  • Neuroendocrine tumours
  • Osteoporosis
  • Parathyroid disease
  • Pituitary disorders
  • Polycystic ovary syndrome (PCOS)
  • Prolactinoma
  • Thyroid cancer
  • Thyroid nodules
  • Thyroid problems
  • Type 2 diabetes
  • Vitamin D deficiency